DrugPatentWatch Database Preview
Jubilant Generics Company Profile
What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?
JUBILANT GENERICS has thirty-nine approved drugs.
Summary for Jubilant Generics
| US Patents: | 0 |
| Tradenames: | 35 |
| Ingredients: | 34 |
| NDAs: | 39 |
| Patent Litigation for Jubilant Generics: | See patent lawsuits for Jubilant Generics |
Drugs and US Patents for Jubilant Generics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Generics | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET;ORAL | 205528-003 | Nov 27, 2015 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Jubilant Generics | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 209156-001 | May 14, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Jubilant Generics | IRBESARTAN | irbesartan | TABLET;ORAL | 203534-002 | Feb 23, 2015 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Jubilant Generics | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202774-002 | Oct 11, 2013 | AB1 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
